Position in ABEO
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$175,616
+$112,655 QoQ
Shares Held
28,417
+102.2% QoQ
Ownership
0.050%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#69
of 125 holders
Holding Since
Sep 2020
8 quarters on record
Voting authority
Sole 92%
Shared 0%
None 8%
Common Shares in ABEO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Russell Investments Group, Ltd. holds $1,504,360,847 across 308 Biotechnology names. ABEO ranks #191 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
336,990 | $167,393,033 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
230,151 | $143,508,345 | |
| 3 | RPRX |
Royalty Pharma plc
|
1,694,250 | $94,996,587 | |
| 4 | INCY |
Incyte Corp
|
425,616 | $48,247,822 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
158,228 | $47,631,369 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
783,148 | $44,811,725 | |
| 7 | LGND |
Ligand Pharmaceuticals Inc
|
120,304 | $38,026,888 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
418,025 | $34,098,295 |
All Filings in ABEO
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $175,616 | 28,417 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $62,961 | 14,054 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $69,009 | 13,095 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $37,392 | 7,082 | Shares | Defined | 2025-11-13 | |
| 2021-06-30 | $1,453,863 | 931,964 | Shares | Defined | 2021-08-04 | |
| 2021-03-31 | $406,914 | 216,444 | Shares | Defined | 2021-05-10 | |
| 2020-12-31 | $339,817 | 216,444 | Shares | Defined | 2021-02-08 | |
| 2020-09-30 | $131,036 | 128,467 | Shares | Sole | 2020-11-09 | |
| No filing history on record for this holder in this stock. | ||||||